These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20497034)

  • 21. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.
    Wenzel D; Bayerl J; Nyström A; Bruckner-Tuderman L; Meixner A; Penninger JM
    Sci Transl Med; 2014 Nov; 6(264):264ra165. PubMed ID: 25429058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
    Eichstadt S; Barriga M; Ponakala A; Teng C; Nguyen NT; Siprashvili Z; Nazaroff J; Gorell ES; Chiou AS; Taylor L; Khuu P; Keene DR; Rieger K; Khosla RK; Furukawa LK; Lorenz HP; Marinkovich MP; Tang JY
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.
    Tolar J; Ishida-Yamamoto A; Riddle M; McElmurry RT; Osborn M; Xia L; Lund T; Slattery C; Uitto J; Christiano AM; Wagner JE; Blazar BR
    Blood; 2009 Jan; 113(5):1167-74. PubMed ID: 18955559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
    Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
    J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
    Hainzl S; Peking P; Kocher T; Murauer EM; Larcher F; Del Rio M; Duarte B; Steiner M; Klausegger A; Bauer JW; Reichelt J; Koller U
    Mol Ther; 2017 Nov; 25(11):2573-2584. PubMed ID: 28800953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction of dog dystrophic epidermolysis bullosa by transplantation of genetically modified epidermal autografts.
    Gache Y; Pin D; Gagnoux-Palacios L; Carozzo C; Meneguzzi G
    J Invest Dermatol; 2011 Oct; 131(10):2069-78. PubMed ID: 21697889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.
    Wong T; Gammon L; Liu L; Mellerio JE; Dopping-Hepenstal PJ; Pacy J; Elia G; Jeffery R; Leigh IM; Navsaria H; McGrath JA
    J Invest Dermatol; 2008 Sep; 128(9):2179-89. PubMed ID: 18385758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients.
    Ryoo YW; Kim BC; Lee KS
    J Dermatol Sci; 2001 Jun; 26(2):125-32. PubMed ID: 11378329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translating the combination of gene therapy and tissue engineering for treating recessive dystrophic epidermolysis bullosa.
    Dakiw Piaceski A; Larouche D; Ghani K; Bisson F; Cortez Ghio S; Larochelle S; Moulin VJ; Caruso M; Germain L
    Eur Cell Mater; 2018 Feb; 35():73-86. PubMed ID: 29441510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.
    Gurevich I; Agarwal P; Zhang P; Dolorito JA; Oliver S; Liu H; Reitze N; Sarma N; Bagci IS; Sridhar K; Kakarla V; Yenamandra VK; O'Malley M; Prisco M; Tufa SF; Keene DR; South AP; Krishnan SM; Marinkovich MP
    Nat Med; 2022 Apr; 28(4):780-788. PubMed ID: 35347281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine type VII collagen distorts outcome in human skin graft mouse model for dystrophic epidermolysis bullosa.
    Bremer J; Kramer D; Eichhorn DS; Gostyński A; Diercks GFH; Jonkman MF; van den Akker PC; Pasmooij AMG
    Exp Dermatol; 2019 Oct; 28(10):1153-1155. PubMed ID: 30019435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa.
    Watt SA; Dayal JH; Wright S; Riddle M; Pourreyron C; McMillan JR; Kimble RM; Prisco M; Gartner U; Warbrick E; McLean WH; Leigh IM; McGrath JA; Salas-Alanis JC; Tolar J; South AP
    PLoS One; 2015; 10(9):e0137639. PubMed ID: 26380979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras.
    Petrova A; Georgiadis C; Fleck RA; Allison L; McGrath JA; Dazzi F; Di WL; Qasim W
    J Invest Dermatol; 2020 Jan; 140(1):121-131.e6. PubMed ID: 31326396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes.
    Dayal JH; Cole CL; Pourreyron C; Watt SA; Lim YZ; Salas-Alanis JC; Murrell DF; McGrath JA; Stieger B; Jahoda C; Leigh IM; South AP
    J Cell Sci; 2014 Feb; 127(Pt 4):740-51. PubMed ID: 24357722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.
    Remington J; Wang X; Hou Y; Zhou H; Burnett J; Muirhead T; Uitto J; Keene DR; Woodley DT; Chen M
    Mol Ther; 2009 Jan; 17(1):26-33. PubMed ID: 19018253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A knot polymer mediated non-viral gene transfection for skin cells.
    Cutlar L; Gao Y; Aied A; Greiser U; Murauer EM; Zhou D; Wang W
    Biomater Sci; 2016 Jan; 4(1):92-5. PubMed ID: 26369723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo.
    Chamorro C; Almarza D; Duarte B; Llames SG; Murillas R; García M; Cigudosa JC; Espinosa-Hevia L; Escámez MJ; Mencía A; Meana A; García-Escudero R; Moro R; Conti CJ; Del Río M; Larcher F
    Exp Dermatol; 2013 Sep; 22(9):601-3. PubMed ID: 23947675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.
    Ortiz-Urda S; Lin Q; Green CL; Keene DR; Marinkovich MP; Khavari PA
    J Clin Invest; 2003 Jan; 111(2):251-5. PubMed ID: 12531881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.